CD8A and ovarian cancer: Paclitaxel treatment is able to increase CD8+ T-cell infiltration of ovarian tumors in a mouse model of ovarian cancer by upregulating MHC-I expression, as well as PD-L1 expression, in an NF-κB-dependent manner [83].